Skip to main content

Table 2 The relationship between differentiation score and other clinical characteristics

From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer

Characteristic

Differentiation

Poor

Moderate

Well

P value

Gender

   

0.107

 Male

49 (59.8%)

27 (32.9%)

6 (7.3%)

 

 Female

41 (75.9%)

12 (22.2%)

1 (1.9%)

 

Age

   

0.284

 ≤55 years

53 (71.6%)

17 (23.0%)

4 (5.4%)

 

 >55 years

37 (59.7%)

22 (35.5%)

3 (4.8%)

 

Chemotherapy regimen

   

0.310

 FOLFOX

24 (60.0%)

14 (35.0%)

2 (5.0%)

 

 CapeOX

17 (65.4%)

9 (34.6%)

0 (0.0%)

 

 TP

16 (76.2%)

5 (23.8%)

0 (0.0%)

 

 Others

33 (67.3%)

11 (22.4%)

5 (10.2%)

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us